UBS cuts EMN target to $77 but keeps Buy
Alpha Vantage · www.marketscreener.com · · AI-summarised by FinFlash
UBS has adjusted its price target for Eastman Chemical Company (EMN) to $77, down from $92, while reiterating a Buy rating on the stock. This update comes after several other analysts also modified their price targets for Eastman Chemical in recent weeks. The company recently reported its Q2 2026 earnings, with adjusted EPS and revenue exceeding analyst estimates.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.